# Anfibatide Phase 1 Clinical Trial in Healthy Volunteers

> **NCT01588132** · PHASE1 · COMPLETED · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 94 (actual)

## Conditions studied

- Coronary Heart Disease
- Coagulation Disorder

## Interventions

- **DRUG:** Anfibatide

## Key facts

- **NCT ID:** NCT01588132
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2012-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01588132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01588132, "Anfibatide Phase 1 Clinical Trial in Healthy Volunteers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01588132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*